Skip to content

Net margin at other companies

Amgen logo
AmgenAMGN
21%+3.6pp
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-529.2%-556pp
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
-411.4%+52.7pp
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
-16.5%-5.0pp
Precigen logo
PrecigenPGEN
-3,656%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
37.1%+0.2pp

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.65B+319%
Enterprise value$1.6B+1,325%
P/S22.8×-379×

Profitability

See full
Operating margin-77.1%-38.4pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Calculated from Septerna, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Septerna, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Septerna, Inc.'s net margin?
Septerna, Inc. (SEPN) reported net margin of -49.9% in Q1 2026.
How has Septerna, Inc.'s net margin changed year-over-year?
Septerna, Inc.'s net margin increased by 99.4% year-over-year, from -8,104.1% to -49.9%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.